Affiliation:
1. Universidade Federal de Alfenas, Brazil
2. Universidade Federal de Alfenas, Brazil; Universidade Estadual de Campinas, Brazil
Abstract
Valsartan (VAL) is a highly selective blocker of the angiotensin II receptor that has been widely used in the treatment of hypertension. Active pharmaceutical ingredient compatibility with excipients (crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose and titanium dioxide) is usually evaluated in solid pharmaceutical development. Compatibility and stability can be evaluated by liquid chromatography. Studies were performed using binary mixtures of 1:1 (w/w) VAL/excipient; samples were stored under accelerated stability test conditions (40 ºC at 75% relative humidity). The results indicate that VAL is incompatible with crospovidone and hypromellose, which reduced the VAL content and gave rise to new peaks in the chromatogram due to degradation products.
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference29 articles.
1. Determination of inherent stability of valsartan by stress degradation and its validation by HPLC;AGRAHARI V;Int. J. Pharm. Clin. Res.,2009
2. Handbook of isolation and characterization of impurities in pharmaceuticals;AHUJA S.,2003
3. Stability evaluation of tocopheryl acetate and ascorbyl tetraisopalmitate in isolation and incorporated in cosmetic formulations using thermal analysis;ALMEIDA M.M.;Braz. J. Pharm. Sci.,2010
4. Estudo termoanalítico de comprimidos revestidos contendo captopril através de termogravimetria (TG) e calorimetria exploratória diferencial (DSC);BAZZO G.C.;Braz. J. Pharm. Sci.,2005
5. Revisiting the solubility concept of pharmaceutical compounds;BLASKO A.;Monatsh. Chem.,2001
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献